JPRN-jRCT1030210550
尚未招募
未知
Providing evidence for long-term care and developing a support system for evidence-based long-term care using Long-term care Information system For Evidence (LIFE) - Providing evidence for long-term care and developing a support system for evidence-based long-term care using Long-term care Information system For Evidence (LIFE)
Tamiya Nananako0 个研究点目标入组 1,620 人2022年1月14日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- A chronic condition or disability, requiring periodic, intermittent, or continuous care.
- 发起方
- Tamiya Nananako
- 入组人数
- 1620
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Residents of geriatric health services facilities.
排除标准
- •Residents whose consent was not obtained.
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
Development of a care scheme using ICT to collaborate with care staff and the external professionals in a day service centerElderly people who are certified as requiring support Elderly people who are certified as requiring long-term careJPRN-UMIN000047593Fukushima Medical University160
进行中（未招募）
不适用
BEAT-CORONA: Building evidence to advance treatments for COVID-19ISRCTN89573163Cambridge University Hospitals NHS Foundation Trust10,000
已完成
不适用
Real world evidence of long-term safety and efficacy in patients treated with durvalumab after concurrent chemoradiation for unresectable stage III NSCLC ;AYAME studynresectable stage III NSCLCJPRN-UMIN000037090AstraZeneca K.K.511
已完成
不适用
Comprehensive study to improve long-term prognosis of patients with idiopathic normal pressure hydrocephalusidiopathic normal pressure hydrocephalus healthy adult volunteerJPRN-UMIN000036290Department of Neuropsychiatry Kochi Medical School, Kochi University,80
进行中（未招募）
1 期
Proof of efficacy, maintenance of efficacy, long-term safety and investigation of the potential for dependence and abuse and the effect of abrupt drug withdrawal of VER-01 in a multicenter study in the treatment of patients with chronic non-specific low back paiFor the treatment of patients with chronic non-specific low back pain when drug treatment is indicated and previous optimised treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2020-000107-36-ATVertanical GmbH808